Not finding it? Sign in to also search OpenAlex live.
-
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study2024 British Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Marinda Meertens, Kim Westerdijk, Eline L. Giraud, Roos F. Bleckman, +16 more
10citations -
Update Breast Cancer 2021 Part 4 – Prevention and Early Stages2022 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christoph Thomssen, Tanja Natascha Fehm, Elmar Stickeler, Peter Andreas Fasching, Wolfgang Janni, Cornelia Kolberg‐Liedtke, +17 more
7citations -
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote replication fork stability and continuous DNA synthesis2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology DNA Repair Mechanisms Open access
Daniel Salas‐Lloret, Néstor García‐Rodríguez, Lisanne Giebel, Arnoud de Ru, Peter A. van Veelen, Pablo Huertas, +2 more
4citations -
Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer2022 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Manfred Welslau, Volkmar Müller, Diana Lüftner, Florian Schütz, Elmar Stickeler, Peter Andreas Fasching, +22 more
3citations -
Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer2023 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Tanja Natascha Fehm, Manfred Welslau, Volkmar Müller, Diana Lüftner, Florian Schütz, Peter Andreas Fasching, +18 more
2citations -
Results of the first international quality control programme for oral targeted oncolytics2023 British Journal of Clinical Pharmacology article Medicine Clinical Laboratory Practices and Quality Control Open access
Eline L. Giraud, Lindsey H. M. te Brake, Erik van den Hombergh, Ingrid M.E. Desar, Dina M. Kweekel, Nielka P. van Erp
1citations -
Update Mammakarzinom 2021 Teil 4 – Prävention und frühe Krankheitsstadien2022 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christoph Thomssen, Tanja Natascha Fehm, Elmar Stickeler, Peter Andreas Fasching, Wolfgang Janni, Cornelia Kolberg‐Liedtke, +17 more
0citations -
Ex vivo 3D micro-tumor testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.2025 Journal of Clinical Oncology conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Cor Doede de Kroon, Judith R. Kroep, Petronella Beatrix Ottevanger, Anne M. van Altena, Els L. van Persijn van Meerten, L. Ceton, +4 more
0citations -
S6K1 and S6K2 regulate homologous recombination DNA repair through control of BRCA1 protein stability2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology DNA Repair Mechanisms
Mariana Marcela Góis, Lais Bonafe, L O Silva, Mariana Camargo Silva Mancini, Rosalie A. Kampen, Isadora Carolina Betim Pavan, +4 more
0citations -
Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien2022 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Manfred Welslau, Volkmar Müller, Diana Lüftner, Florian Schütz, Elmar Stickeler, Peter Andreas Fasching, +22 more
0citations -
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis2022 International Journal of Gynecological Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Bich Doan Nguyen-Sträuli, Joanna Baum, Philipp Meyer-Wilmes, A Kreklau, Christina Buschmann, Nabila El Ouardi, +6 more
3citations -
469 Survey on the usage of PARP-inhibitor therapy in Germany – a national NOGGO/JAGO-AGO intergroup study2021 International Journal of Gynecological Cancer article Medicine PARP inhibition in cancer therapy Open access
Bich Doan Nguyen-Sträuli, P Meyer-Wilmes, Joanna Baum, A Kreklau, Christina Buschmann, S Boz, +6 more
0citations -
Post(neo)adjuvante Therapiekonzepte – Möglichkeiten der Therapieoptimierung2022 Der Gynäkologe article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Natalia Krawczyk, Tanja Natascha Fehm, Elmar Stickeler, Christoph Thomssen, Marc Thill, Maggie Banys‐Paluchowski
0citations -
Post(neo)adjuvante Therapiekonzepte – Möglichkeiten der Individualisierung2024 Die Gynäkologie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Natalia Krawczyk, Tanja Natascha Fehm, Elmar Stickeler, Christoph Thomssen, Marc Thill, Franziska Fick, +2 more
0citations -
PARP-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional HRD testing2026 International Journal of Gynecological Cancer article Medicine PARP inhibition in cancer therapy Open access
Merel Vegter, Lise M. van Wijk, CJH Kramer, M. Jalving, T. Bosse, Dik C. van Gent, +9 more
0citations